Te Diagnosis and Treatment of Autoimmune Encephalitis

키워드

참고문헌 (89)

1. Dalmau J, "Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis", Lancet Neurol, 10, pp.63~74 (2011)
2. Höftberger R, "Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients", Neurology, 81, pp.1500~1506 (2013)
3. Armangue T, "Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients", J Pediatr, 162, pp.850~856 (2013)
4. McKeon A, "Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype", JAMA Neurol, 70, pp.44~50 (2013)
5. Hutchinson M, "Progressive encephalomyelitis, rigidity, and myoclonus:a novel glycine receptor antibody", Neurology, 71, pp.1291~1292 (2008)
6. Dale RC, "Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders", Brain, 135(Pt 11), pp.3453~3468 (2012)
7. Walker KG, "An update on the treatment of Sydenham’s chorea: the evidence for established and evolving interventions", Ther Adv Neurol Disord, 3, pp.301~309 (2010)
8. Lancaster E, "Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen", Lancet Neurol, 9, pp.67~76 (2010)
9. Petit-Pedrol M, "Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies", Lancet Neurol, 13, pp.276~286 (2014)
10. Irani SR, "Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis", Ann Neurol, 69, pp.892~900 (2011)
11. Isaacs H, "A Syndrome of continuous muscle-fibre activity", J Neurol Neurosurg Psychiatry, 24, pp.319~325 (1961)
12. Isaacs H, "Continuous muscle fibre activity in an Indian male with additional evidence of terminal motor fibre abnormality", J Neurol Neurosurg Psychiatry, 30, pp.126~133 (1967)
13. Lancaster E, "Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia", Ann Neurol, 69, pp.303~311 (2011)
14. Irani SR, "Antibodies to Kv1 potassium channel-complex proteins leucinerich, glioma inactivated 1 protein and contactin-associated protein-2in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia", Brain, 133, pp.2734~2748 (2010)
15. Sanna G, "Central nervous system involvement in systemic lupus erythematosus:cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations", Lupus, 9, pp.573~583 (2000)
16. Chiewthanakul P, "Clinical features and predictive factors in neuropsychiatric lupus", Asian Pac J Allergy Immunol, 30, pp.55~60 (2012)
17. Shahrizaila N, "Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome", J Neurol Neurosurg Psychiatry, 84, pp.576~583 (2013)
18. Venkatesan A, "Epidemiology and outcomes of acute encephalitis", Curr Opin Neurol, 28, pp.277~282 (2015)
19. Lee DW, "Epidemiology of Japanese encephalitis in South Korea, 2007-2010", Int J Infect Dis, 16, pp.e448~e452 (2012)
20. 황지혜, "The First Reported Case of West Nile Encephalitis in Korea", Journal of Korean Medical Science, 30(3), pp.343~345 (2015), 대한의학회
21. Saylor D, "Acute encephalitis in the immunocompromised individual", Curr Opin Infect Dis, 28, pp.330~336 (2015)
22. Pruitt AA, "Nervous system viral infections in immunocompromised hosts", Handb Clin Neurol, 123, pp.685~704 (2014)
23. Agut H, "Laboratory and clinical aspects of human herpesvirus 6 infections", Clin Microbiol Rev, 28, pp.313~335 (2015)
24. Alex J. Fay, "Pediatric Hemorrhagic Brainstem Encephalitis Associated With HHV-7 Infection", Pediatric Neurology, 53(6), pp.523~526 (2015), Elsevier BV[DOI]
25. Yamamoto S, "Human herpesvirus-6 infection-associated acute encephalopathy without skin rash", Brain Dev, 37, pp.829~832 (2015)
26. Kasberg-Koniarczyk HL, "Human herpesvirus-6 encephalitis after hematopoietic stem cell transplantation", J Adv Pract Oncol, 5, pp.373~378 (2014)
27. Prichard MN, "The development of new therapies for human herpesvirus 6", Curr Opin Virol, 9, pp.148~153 (2014)
28. Yamamoto W, "Human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen", Clin Transplant, 28, pp.540~545 (2014)
29. Wilson MR, "Actionable diagnosis of neuroleptospirosis by next-generation sequencing", N Engl J Med, 370, pp.2408~2417 (2014)
30. Naccache SN, "Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing", Clin Infect Dis, 60, pp.919~923 (2015)
31. Michael R. Wilson, "Diagnosing balamuthia mandrillaris encephalitis with metagenomic deep sequencing", Annals of Neurology, 78(5), pp.722~730 (2015), Wiley-Blackwell[DOI]
32. Hoffmann B, "A variegated squirrel bornavirus associated with fatal human encephalitis", N Engl J Med, 373, pp.154~162 (2015)
33. Pruitt AA, "Infections of the cerebellum", Neurol Clin, 32, pp.1117~1131 (2014)
34. Lallas M, "Wernicke encephalopathy in children and adolescents", World J Pediatr, 10, pp.293~298 (2014)
35. Juhasz-Pocsine K, "Neurologic complications of gastric bypass surgery for morbid obesity", Neurology, 68, pp.1843~1850 (2007)
36. Jearanaisilp S, "Neoplastic meningitis: a retrospective review of clinical presentations, radiological and cerebrospinal fluid findings", J Med Assoc Thai, 97, pp.870~877 (2014)
37. Lancaster E, "Immunoglobulin G antibodies to the N-Methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses", Ann Neurol, 77, pp.183~ (2015)
38. Masdeu JC, "Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia", Am J Psychiatry, 169, pp.1120~1121 (2012)
39. Gresa-Arribas N, "Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study", Lancet Neurol, 13, pp.167~177 (2014)
40. Hart IK, "Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia", Ann Neurol, 41, pp.238~246 (1997)
41. Lai M, "Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series", Lancet Neurol, 9, pp.776~785 (2010)
42. Paterson RW, "Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre", J Neurol Neurosurg Psychiatry, 85, pp.625~630 (2014)
43. Fenalti G, "GAD65 as a prototypic autoantigen", J Autoimmun, 31, pp.228~232 (2008)
44. Kirshner HS, "Hashimoto’s encephalopathy: a brief review", Curr Neurol Neurosci Rep, 14, pp.476~ (2014)
45. Sili U, "Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients", J Clin Virol, 60, pp.112~118 (2014)
46. Tobin WO, "DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients", Neurology, 83, pp.1797~1803 (2014)
47. Heine J, "Imaging of autoimmune encephalitis – Relevance for clinical practice and hippocampal function", Neuroscience, 309, pp.68~83 (2015), Elsevier BV[DOI]
48. Sutter R, "Electroencephalography for diagnosis and prognosis of acute encephalitis", Clin Neurophysiol, 126, pp.1524~1531 (2015)
49. Titulaer MJ, "Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men", Neurology, 82, pp.550~551 (2014)
50. Schmitt SE, "Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis", Neurology, 79, pp.1094~1100 (2012)
51. Bai HX, "Diagnostic value and safety of brain biopsy in patients with cryptogenic neurological disease:a systematic review and meta-analysis of 831 cases", Neurosurgery, 77, pp.283~295 (2015)
52. Dalmau J, "De tection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis", sensory neuronopathy, 1991, pp.41, 1757~1764
53. Dalmau J, "Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma", Ann Neurol, 61, pp.25~36 (2007)
54. Moscato EH, "Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies", Eur J Neurosci, 32, pp.298~309 (2010)
55. Planagumà J, "Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice", Brain, 138(Pt 1), pp.94~109 (2015)
56. Irani SR, "Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype", Brain, 136(Pt 10), pp.3151~3162 (2013)
57. Ohkawa T, "Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors", J Neurosci, 33, pp.18161~18174 (2013)
58. Lai M, "AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location", Ann Neurol, 65, pp.424~434 (2009)
59. Sillevis Smitt P, "Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor", N Engl J Med, 342, pp.21~27 (2000)
60. Lancaster E, "Antibodies to metabotropic glutamate receptor 5in the Ophelia syndrome", Neurology, 77, pp.1698~1701 (2011)
61. Carr I, "The Ophelia syndrome: memory loss in Hodgkin’s disease", Lancet, 1, pp.844~845 (1982)
62. de Graaff E, "Identification of delta", notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration, 2012, pp.71, 815~824
63. Greene M, "Antibodies to Delta", notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma, 2014, pp.71, 1003~1008
64. Bernal F, "Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease", Neurology, 60, pp.230~234 (2003)
65. Carvajal-González A, "Glycine receptor antibodies in PERM and related syndromes:characteristics, clinical features and outcomes", Brain, 137(Pt 8), pp.2178~2192 (2014)
66. Gresa-Arribas N, "Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity", PLoS One, 10, pp.e0121364~ (2015)
67. Ariño H, "Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies", JAMA Neurol, 72, pp.874~881 (2015)
68. Bauerfeind R, "Amphiphysin I is associated with coated endocytic intermediates and undergoes stimulation-dependent dephosphorylation in nerve terminals", J Biol Chem, 272, pp.30984~30992 (1997)
69. Murinson BB, "Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease", Neurology, 71, pp.1955~1958 (2008)
70. Graus F, "Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients", Brain, 124(Pt 6), pp.1138~1148 (2001)
71. Brieva-Ruíz L, "Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study", Clin Neurol Neurosurg, 110, pp.1044~1046 (2008)
72. Chan KH, "ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity", Ann Neurol, 50, pp.301~311 (2001)
73. Peterson K, "Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibodypositive patients", Neurology, 42, pp.1931~1937 (1992)
74. Rojas I, "Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies", Neurology, 55, pp.713~715 (2000)
75. Greenlee JE, "Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures", J Neuropathol Exp Neurol, 69, pp.997~1007 (2010)
76. Vernino S, "New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity", Ann Neurol, 47, pp.297~305 (2000)
77. Cross SA, "Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG", Ann Neurol, 54, pp.38~50 (2003)
78. Hampton CW, "Encephalomyeloneuropathy with CRMP-5 antibodies in a patient with a primary mediastinal serinoma", Neurol Neuroimmunol Neuroinflamm, 2, pp.e82~ (2015)
79. Nakae Y, "Hemichorea in a thymoma patient without anti-CRMP-5 antibody", Neurol Sci, 35, pp.629~630 (2014)
80. Dalmau J, "Clinical analysis of anti-Ma2-associated encephalitis", Brain, 127(Pt 8), pp.1831~1844 (2004)
81. Huijbers MG, "The expanding field of IgG4-mediated neurological autoimmune disorders", Eur J Neurol, 22, pp.1151~1161 (2015)
82. Clowse ME, "Ovarian preservation by GnRH agonists during chemotherapy:a meta-analysis", J Womens Health (Larchmt), 18, pp.311~319 (2009)
83. Gable MS, "The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project", Clin Infect Dis, 54, pp.899~904 (2012)
84. Titulaer MJ, "Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study", Lancet Neurol, 12, pp.157~165 (2013)
85. Leypoldt F, "Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report", Neurology, 81, pp.1637~1639 (2013)
86. Chow FC, "Use of clinical and neuroimaging characteristics to distinguish temporal lobe herpes simplex encephalitis from its mimics", Clin Infect Dis, 60, pp.1377~1383 (2015)
87. Fallon BA, "Inflammation and central nervous system Lyme disease", Neurobiol Dis, 37, pp.534~541 (2010)
88. Chancey C, "The global ecology and epidemiology of West Nile virus", Biomed Res Int, 2015, pp.376230~ (2015)
89. DeLone DR, "Disseminated aspergillosis involving the brain: distribution and imaging characteristics", AJNR Am J Neuroradiol, 20, pp.1597~1604 (1999)

관련 논문AI추천